Hamilton Lane Inc. $HLNE Shares Sold by Russell Investments Group Ltd.

by · The Cerbat Gem

Russell Investments Group Ltd. cut its stake in shares of Hamilton Lane Inc. (NASDAQ:HLNEFree Report) by 16.2% in the 2nd quarter, Holdings Channel reports. The fund owned 66,272 shares of the company’s stock after selling 12,783 shares during the quarter. Russell Investments Group Ltd.’s holdings in Hamilton Lane were worth $9,419,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC acquired a new position in shares of Hamilton Lane in the first quarter valued at approximately $432,772,000. Champlain Investment Partners LLC purchased a new position in Hamilton Lane in the 1st quarter valued at $112,887,000. T. Rowe Price Investment Management Inc. grew its position in Hamilton Lane by 63.4% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 1,275,000 shares of the company’s stock valued at $189,555,000 after buying an additional 494,637 shares during the last quarter. Nuveen LLC acquired a new position in Hamilton Lane in the 1st quarter valued at $24,334,000. Finally, Janney Montgomery Scott LLC raised its position in Hamilton Lane by 2,139.2% during the 2nd quarter. Janney Montgomery Scott LLC now owns 103,360 shares of the company’s stock worth $14,690,000 after buying an additional 98,744 shares during the last quarter. 97.40% of the stock is currently owned by hedge funds and other institutional investors.

Hamilton Lane Trading Down 0.5%

Shares of HLNE opened at $121.15 on Wednesday. The company has a debt-to-equity ratio of 0.29, a current ratio of 4.32 and a quick ratio of 4.32. Hamilton Lane Inc. has a 1-year low of $111.98 and a 1-year high of $196.95. The stock has a market cap of $6.76 billion, a price-to-earnings ratio of 23.30 and a beta of 1.23. The firm has a 50 day simple moving average of $124.45 and a 200-day simple moving average of $141.96.

Hamilton Lane (NASDAQ:HLNEGet Free Report) last announced its earnings results on Tuesday, November 4th. The company reported $1.54 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.46. The firm had revenue of $190.88 million for the quarter, compared to analysts’ expectations of $171.86 million. Hamilton Lane had a return on equity of 29.47% and a net margin of 30.66%. Equities analysts forecast that Hamilton Lane Inc. will post 4.97 EPS for the current fiscal year.

Hamilton Lane Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Friday, December 19th will be issued a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Friday, December 19th. Hamilton Lane’s dividend payout ratio is presently 39.13%.

Insider Buying and Selling at Hamilton Lane

In other news, CEO Juan Delgado-Moreira purchased 8,000 shares of the stock in a transaction on Friday, November 7th. The stock was purchased at an average price of $130.35 per share, with a total value of $1,042,800.00. Following the completion of the transaction, the chief executive officer owned 1,314,447 shares in the company, valued at approximately $171,338,166.45. The trade was a 0.61% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder River 5 Ltd French sold 150,000 shares of the business’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $146.51, for a total value of $21,976,500.00. Following the sale, the insider owned 330,015 shares of the company’s stock, valued at $48,350,497.65. The trade was a 31.25% decrease in their position. The SEC filing for this sale provides additional information. 22.21% of the stock is owned by insiders.

Analyst Ratings Changes

Several analysts have recently commented on the stock. BMO Capital Markets began coverage on shares of Hamilton Lane in a research note on Friday, October 3rd. They issued an “outperform” rating and a $150.00 target price for the company. Morgan Stanley reduced their price objective on shares of Hamilton Lane from $169.00 to $154.00 and set an “equal weight” rating for the company in a research report on Tuesday, October 21st. Keefe, Bruyette & Woods boosted their target price on Hamilton Lane from $150.00 to $158.00 and gave the stock an “outperform” rating in a research report on Thursday, November 6th. Weiss Ratings downgraded Hamilton Lane from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Saturday, October 25th. Finally, Wall Street Zen raised Hamilton Lane from a “sell” rating to a “hold” rating in a report on Sunday, November 9th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Hamilton Lane presently has an average rating of “Moderate Buy” and a consensus target price of $159.29.

Get Our Latest Stock Analysis on HLNE

Hamilton Lane Company Profile

(Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Further Reading

Want to see what other hedge funds are holding HLNE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hamilton Lane Inc. (NASDAQ:HLNEFree Report).